前收市價 | 0.5200 |
開市 | 0.5500 |
買盤 | 0.3500 |
賣出價 | 0.6000 |
拍板 | 185.00 |
到期日 | 2024-06-21 |
今日波幅 | 0.5500 - 0.5500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 25 |
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.